<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00351598</url>
  </required_header>
  <id_info>
    <org_study_id>TROG 99.05</org_study_id>
    <nct_id>NCT00351598</nct_id>
  </id_info>
  <brief_title>Lung Tumour Volume Database</brief_title>
  <official_title>Tumour Volume as an Independent Prognostic Factor in Patients With Non-Small Cell Lung Cancer - A Protocol for a Prospective Database.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Trans Tasman Radiation Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peter MacCallum Cancer Centre, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Trans Tasman Radiation Oncology Group</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main aim is to determine, in patients with locoregional, non-small cell lung cancer&#xD;
      (NSCLC) treated by definitive radiotherapy, the influence on survival of the volume of&#xD;
      primary tumour, as measured from CT imaging, after adjusting for the effect of the current&#xD;
      TNM staging system and other known prognostic factors (especially ECOG performance and weight&#xD;
      loss).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with locoregional non small cell lung cancer are registered on study after tumour&#xD;
      volumes are outlined by a radiologist and prior to the commencement of any treatment.&#xD;
&#xD;
      All patients must have recorded the volume of disease in the primary tumour (and of involved&#xD;
      nodes &gt; 1 cm diameter) as measured from a CT scan performed according to a standard set of&#xD;
      conditions.&#xD;
&#xD;
      Following registration patients are treated with Definitive radiotherapy with or without&#xD;
      chemotherapy. Follow-up will occur with the collection of a minimum amount of data every 12&#xD;
      months from the date of registration on study.&#xD;
&#xD;
      Quality Assurance procedures will be implemented with each site that participates in the&#xD;
      study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 1999</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">February 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>End of Study</time_frame>
    <description>Survival duration defined as the time from date of registration until death from any cause</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">531</enrollment>
  <condition>Non-Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Patients with loco-regional, NSCLC treated by definitive radiotherapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Definitive Radiotherapy</intervention_name>
    <description>60Gy in 6 weeks, 50Gy in 4 weeks. Each individual fraction should not exceed 2.5Gy.</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Radiation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with loco-regional non-small cell lung cancer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Must satisfy ALL of the following&#xD;
&#xD;
          -  NSCLC - histological or cytological diagnosis of non-small cell lung cancer&#xD;
&#xD;
          -  Intra-thoracic disease - disease is confined to the primary site, with or without&#xD;
             intrathoracic lymph nodes&#xD;
&#xD;
          -  CT planning - CT imaging of the thorax has been performed as part of the planning&#xD;
             procedure&#xD;
&#xD;
          -  Definitive radiotherapy - it is planned to give definitive radiotherapy with or&#xD;
             without chemotherapy (prior to, during or after radiotherapy). Definitive radiotherapy&#xD;
             is defined as 60 Gy in 6 weeks, 50 Gy in 4 weeks or at least the equivalent of either&#xD;
             of these. The size of each individual; fraction should not exceed 2.5 Gy.&#xD;
&#xD;
          -  Measurable disease - the primary tumour and nodes with maximum diameter greater than&#xD;
             1cm represent measurable disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        A patient satisfying ANY of the following is ineligible&#xD;
&#xD;
          -  Symptomatic or radiological evidence of metastatic disease&#xD;
&#xD;
          -  Prior treatment for non-small cell lung cancer&#xD;
&#xD;
          -  Surgical resection is part of initial treatment&#xD;
&#xD;
          -  Palliative radiotherapy planned&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Ball</last_name>
    <role>Study Chair</role>
    <affiliation>Peter MacCallum Cancer Centre, Australia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St George Hospital</name>
      <address>
        <city>Kogarah</city>
        <state>New South Wales</state>
        <zip>2217</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>New South Wales</state>
        <zip>1871</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newcastle Mater Misericordiae Hospital</name>
      <address>
        <city>Newcastle</city>
        <state>New South Wales</state>
        <zip>2298</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Wentworthville</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mater QRI</name>
      <address>
        <city>South Brisbane</city>
        <state>Queensland</state>
        <zip>4101</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>East Coast Cancer Centre</name>
      <address>
        <city>Tugun</city>
        <state>Queensland</state>
        <zip>4224</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5000</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peter MacCallum Cancer Centre</name>
      <address>
        <city>East Melbourne</city>
        <state>Victoria</state>
        <zip>3002</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Health</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <zip>3081</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alfred Hospital</name>
      <address>
        <city>Prahran</city>
        <state>Victoria</state>
        <zip>3181</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auckland Hospital</name>
      <address>
        <city>Auckland</city>
        <zip>1001</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National University Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>New Zealand</country>
    <country>Singapore</country>
  </location_countries>
  <link>
    <url>http://www.trog.com.au</url>
    <description>Click here for more information about this study on the TROG official website</description>
  </link>
  <results_reference>
    <citation>Ball DL, Fisher R, Burmeister B, Graham P, Joseph D, Penniment M, Krawitz H, Wheeler G, Poulsen M, Vinod S, McClure B. Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 database. J Thorac Oncol. 2006 Sep;1(7):667-72.</citation>
    <PMID>17409934</PMID>
  </results_reference>
  <verification_date>July 2014</verification_date>
  <study_first_submitted>July 11, 2006</study_first_submitted>
  <study_first_submitted_qc>July 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2006</study_first_posted>
  <last_update_submitted>July 31, 2014</last_update_submitted>
  <last_update_submitted_qc>July 31, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tumour Volume</keyword>
  <keyword>Prognostic value</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

